help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on September 4, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2007-0932
A more recent version of this article appeared on November 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
92/11/4380    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Richert, L.
Right arrow Articles by Ferrari, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Richert, L.
Right arrow Articles by Ferrari, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*OMIM
*UniGene
Related Collections
Right arrow Calcium and Bone Metabolism
Right arrow Metabolism
Right arrow Pediatric Endocrinology

Submitted on April 24, 2007
Accepted on August 27, 2007

Bone Mass In Prepubertal Boys Is Associated With a Gln223Arg Amino Acid Substitution in the Leptin Receptor

Laura Richert, Thierry Chevalley, Danielle Manen, Jean-Philippe Bonjour, René Rizzoli, and Serge Ferrari*

Service of Bone Diseases, WHO Collaborating Center for Osteoporosis Prevention, Department of Rehabilitation and Geriatrics, University Hospital of Geneva, Switzerland

* To whom correspondence should be addressed. E-mail: serge.ferrari{at}medecine.unige.ch.

Objective: The contribution of leptin to bone mass acquisition in humans remains unclear. We investigated the association of the Gln223Arg polymorphism in the leptin receptor gene (LEPR) with bone mineral content (BMC) and areal bone mineral density (aBMD) in pre-pubertal boys, and LEPR interaction with vitamin D receptor (VDR) genotypes (Bsm1 and Fok1).

Design: In a cross-sectional design with a longitudinal follow-up, DXA measurements at the lumbar spine, hip, femoral diaphysis, and radius were performed at baseline (mean age 7.4 ± 0.4 yrs) and two years later in 222 healthy Caucasian males.

Results: LEPR genotypes were significantly associated with baseline BMC at the hip (P=0.017), femur diaphysis (P=0.019) and radius (P=0.007), with height (P=0.041) as well as with physical activity (P=0.016). Associations with height and BMC at femur diaphysis and radius remained significant after two years. Significant differences in two-year bone mass gain at the spine and femur neck were also found among LEPR genotypes. In contrast, adjusting BMC for projected bone area (aBMD) and/or weight, height and physical activity, resulted in a weak association only at the femur (P=0.014–0.054). VDR polymorphisms were not associated with BMC/aBMD, but significant interactions occurred between VDR Fok1 and LEPR genotypes.

Conclusions: The LEPR Gln223Arg polymorphism was associated with bone mass in growing boys. The association, however, was markedly dependent on bone area, body size and physical activity, in addition to VDR genetic variation, suggesting that the leptin system may modulate bone mass in humans mostly through indirect mechanisms.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society